Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

This study has been terminated.
Information provided by (Responsible Party):
American-European Congress of Ophthalmic Surgery Identifier:
First received: September 19, 2011
Last updated: June 27, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)